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Background: Nowadays, palliative care is considered as a care continuum that may start early in the course of the
disease. In order to address the evolving needs of patients for palliative care in time, GPs should be aware in good
time of the diagnosis and of the imminence of death. The aim of the study was to gain insight into how long
before a non-sudden death the diagnosis of the disease ultimately leading to death is made and on what kind of
information the diagnosis is based. In addition, we aimed to explore when, and based on what kind of information,
GPs become aware that death of a patient will be in the foreseeable future.
Methods: A written questionnaire focusing on the GPs’ experiences with their last patient who died non-suddenly
was sent to a random representative sample of 850 GPs in the Netherlands.
Results: The data were analysed of the 297 GPs who responded. 76% of the reported cases were cancer patients
and 24% were patients with another non-sudden cause of death. The diagnosis was made only in the last week of
life for 15% of the non-cancer patients and 1% of the patients with cancer. GPs were most likely to have been
informed of the diagnosis by the medical specialist, although particularly in the case of non-cancer patients GPs
also relied on their own assessment of the diagnosis or on other information sources.
The GP remained unaware that the patient would die in the foreseeable future until the last week of life in 26% of
the non-cancer group, while this was the case for only 6% of the cancer patients. GP’s awareness was most likely to
be based on the GP’s own observations of problems and/or symptoms.
Conclusions: The GP often only becomes aware of a fatal diagnosis and of death in the foreseeable future at a late
stage in the disease trajectory, particularly in the case of non-cancer patients. It can be assumed that if the
diagnosis and the nearing death are only recognised at a late stage, palliative care is either started at a very late
stage or not at all.
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Nowadays, care providers, policymakers and researchers
are increasingly aware that palliative care is broader than
terminal care. Figure 1 shows the ‘model’ of Lynn and
Adamson (2003), displaying palliative care as part of a
care continuum that starts early in the trajectory of a* Correspondence: s.claessen@vumc.nl
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reproduction in any medium, provided the orchronic illness and that ends with the death of the pa-
tient and aftercare for relatives [1].
Timely diagnosis of a life-threatening disease as well as
timely awareness that death is near are important in enab-
ling anticipatory measures to be taken to cope with the
frequent increase in symptoms and problems, in enabling
crises to be prevented and in allowing patients’ needs for
palliative care to be met fully. In addition, if a GP becomes
aware of a fatal diagnosis and of death in the foreseeable
future only in a very late stage of the disease, this impedes
a timely start to end-of-life care (‘palliative care in the lastal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Palliative care as a care continuum (Lynn and
Adamson 2003).
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fessional in palliative care [3,4], it is important that the GP
is aware in good time of a diagnosis of a life-threatening
condition and of the prognosis that a patient will die in
the foreseeable future.
There is literature available about the care of people
who died from malignancies, heart failure, respiratory
diseases or renal failure [5-7]. However, to our know-
ledge, no previous studies have been conducted on what
kind of information GPs use and in what phase of the
illness trajectory GPs become aware of the diagnosis. Yet
some studies have been conducted on how professionals
identify that a patient will die in the foreseeable future
[8,9]. Sullivan et al. performed secondary analyses of in-
terviews with hospital physicians [9]. These authors
found that 38% of the physicians were uncertain when
the patient was admitted whether the patient would die
during this hospitalisation. However, over the course of
hospitalisation 86% reported that they knew that death
was imminent. Eleven percent of physicians reported an-
ticipating the patient would die weeks before the death,
57.1% days before, and 18.3% hours before the death.
Earlier recognition of imminent death was associated
with greater reported overall satisfaction of the physi-
cians with the end-of-life care provided to the patient.
Furthermore, Abarshi et al. investigated how long before
death GPs recognise that patients were likely to die in
the near future [8]. They reported that GPs never
recognised that the patient would die in the foreseeable
future in about a third of their patients with a non-
sudden death. However, the study of Abarshi et al. did
not explore which sources of information the GPs used
to identify death in the foreseeable future.
In addition, so far it has remained unclear whether
there are differences between cancer patients and other
patients with a non-sudden death cause regarding the
‘when and how’ of GPs’ identification of a fatal diagnosis
and of death in the foreseeable future. However, com-
mon disease trajectories differ between patient groups[6,10,11] which may also have consequences for GPs’
awareness of the diagnosis and the awareness that the
patient's death will be in the foreseeable future. Lynn
and Adamson and also Murray distinguished three com-
mon disease trajectories leading to a non-sudden death
[1,12]. First there is the common illness trajectory of
patients with cancer, which is reasonably predictable and
usually characterised by a clear terminal phase. In con-
trast, trajectories in patients with COPD or heart failure
are often characterised by intermittent exacerbations
and remissions and a relatively sudden death. In the frail
elderly, such as people with dementia, there is often a
prolonged gradual decline towards death.
Since disease trajectories vary, it can be expected that
the timing of the GPs' recognition of the fatal diagnosis
and of the awareness that the patient would die in the
foreseeable future are also different.
We conducted this study among a random sample of
GPs in the Netherlands in order to gain more insight
into the ‘how and when’ of GPs’ identification of a fatal
diagnosis and of the foreseen death. The following re-
search questions are addressed:
1 How long before death is the diagnosis of a disease
ultimately leading to death made in cancer patients
and in patients with another non-sudden cause of
death?
2 On the basis of what kind of information sources do
GPs become aware of the diagnosis of the disease
leading to death?
3 How long before the death are GPs aware that death
will be in the foreseeable future in cancer patients
versus patients with another non-sudden cause of
death?
4 On the basis of what kind of information sources do
GPs become aware that a patient will die in the
foreseeable future?
Methods
Design
A retrospective cross-sectional design was used based
on survey data.
Study population and setting
A random sample of 850 Dutch GPs participated in this
survey. The sample was drawn from a national registra-
tion base (NIVEL) with the addresses and background
characteristics of all GPs working in the Netherlands.
Pilot and content of the questionnaire
The content of the questionnaire was largely based on
existing questionnaires: in particular a questionnaire
about end-of life care by GPs [13-15] and a registration
form used by GPs participating in the Dutch Sentinel
Table 1 Characteristics of sample of GPs in percentages
Sample
Non-respondents
(n = 521)
Respondents
(n = 297)
P-value*
Gender 0.717
Male 58.5 57.2
Female 41.5 42.8
Age 0.720
25–39 25.0 27.0
40–54 46.8 47.2
≥ 55 28.2 25.9
Solo practice 0.169
Yes 17.9 14.1
No 82.1 85.9
Degree of urbanisation 0.787
Extremely urbanised/
strongly urbanised
47.2 45.1
Moderately urbanised 18.8 20.5
Hardly urbanised/
not urbanised
34.0 34.4
*Chi-square analysis.
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their answers on the case of their last patient with a
non-sudden death. We explained in the questionnaire
that this could be a patient who died of cancer, heart
failure, COPD, stroke, dementia, other chronic diseases
or “gradual decline because of frailty and old age”.
The questions used for answering the research questions
addressed in this paper are shown in Additional file 1.
Face validity, content validity and comprehensibility of
the draft questionnaire were assessed by the steering
committee, which included three scientists in the field of
end-of-life care and two GPs. The usability and compre-
hensibility were tested further among ten other GPs.
This resulted in some minor revisions, e.g. regarding the
time period to which questions relate. The final version
of the questionnaire consisted of 44 semi-structured
questions.
The random sample of 850 GPs received the final ques-
tionnaire, together with an explanatory letter and return
envelope, in the summer of 2010. Reminders were sent
after four weeks and seven weeks.
Statistical analysis
All questionnaires were scrutinised for errors and missing
data, and the data were digitised by scanning. A random
sample of 15 questionnaires was checked for errors arising
during scanning. No errors were found.
Descriptive analyses and Chi-square analyses were used
to answer the research questions addressed in this paper.
A Fisher exact test was used instead of a Chi-square test if
the expected value for one or more of the cells was less
than five.
Ethics
GPs received information about the aim and content of
the research in an explanatory letter, which was sent
together with the questionnaire. The anonymity of the
GPs and their patients was strictly preserved throughout
the data entry and analysis process.
According to Dutch law, no approval of a Medical Ethics
Committee is needed for surveys among care professionals
and for post-mortem anonymous patient data.
Results
Response
Seventeen questionnaires were returned as ‘undeliverable’
(mainly because the address was unknown or incorrect),
four other questionnaires were returned uncompleted be-
cause the GP was absent due to long-term illness or ma-
ternity leave and eleven were returned uncompleted
because the GP had no experience with palliative care.
Hence, 818 of the 850 GPs in the sample were considered
eligible for this study. A total of 297 questionnaires were
completed and returned (the net response rate was 36%,i.e. 297/818). About half of the respondents (47%) were
aged between 40 and 54. The majority were male (57%)
and 86% worked in a two-person or group practice
(Table 1).
No differences between non-respondents and respon-
dents were observed regarding gender, age, whether or not
the GP had a solo practice, and degree of urbanisation
(Table 1).
Characteristics of the deceased patients dealt with in the
GPs’ questionnaires
Of the 297 patients described by the GPs as being their
last patient with a non-sudden death, 153 were female
(52%). The median age at death was 72 (range: 39–103).
The majority (76%) died from cancer, while 24% had an-
other non-sudden cause of death such as heart failure
(33%), general decline because of old age (27%), asthma/
COPD (9%), dementia (6%), amyotrophic lateral sclerosis
(4%), renal failure (4%), stroke (1%), other (11%), and an
unknown non-cancer cause of death (6%).
70% of the patients died at home, 13% in a care home
and 10% of the patients died in a hospital.
Time between the diagnosis of the disease ultimately
leading to death and the death
The diagnosis of the disease leading to the non-sudden
death was only made in the last six months of life in 41%
of the group with cancer and 49% of the non-cancer group
(see Table 2, difference is not significant). The diagnosis
was only made in the last month before death for 29% of
Table 2 Timing of the diagnosis of the disease ultimately leading to death and sources of information
Cancer Non-cancer
Timing of diagnosis n = 220** n = 65** P-value*
(%) (%)
Not until last year before death (also including last six months, last month and last week) 120 (54) 39 (60) 0.437
Not until last six months before death (also including last month and last week) 90 (41) 32 (49) 0.234
Not until last month before death (also including last week) 14 (6) 19 (29) <0.001
Not until last week before death 1 (1) 10 (15) <0.001
GPs’ information about diagnosis was based on: (more than one answer possible) Cancer Non-cancer
n = 226 n = 71
(%) (%)
Information from the medical specialist 165 (73) 43 (61) 0.046
GPs’ own diagnostics 80 (35) 35 (49) 0.036
Information from the patient 34 (15) 5 (7) 0.082
Information from relatives 7 (3) 9 (13) 0.004
Other 8 (4) 1 (1) 0.692
Don’t know 1 (0.4) 0 (0) 1.000
Not applicable 1 (0.4) 2 (3) 0.143
*Chi-square analyses: significant differences between group with cancer and non-cancer group are in bold.
**12 missing values, including ‘don’t know/not applicable’ answers.
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(p < 0.001). The diagnosis was only made in the last week
before death in 15% of the non-cancer patients versus 1%
of the cancer patients (p < 0.001).
In 73% of the patients who died from cancer and 61% of
the non-cancer patients (p < 0.05) GPs knew the diagnosis
through information from the medical specialist - whether
or not combined with other sources of information
(Table 2). Particularly in non-cancer patients, GPs (also)
relied on their own diagnostics (in 49% of the non-cancer
patients versus 35% of the cancer patients, p < 0.05). Infor-
mation from relatives was also more often a source of
information in non-cancer patients (13%) than in cancer
patients (3%, p < 0.01). In addition, GPs sometimes re-
ceived information from the patients themselves about the
diagnosis (see Table 2).
Timing of GPs’ awareness of death in the foreseeable
future and sources of information
In 86% of the group with cancer and 94% of the non-
cancer group, GPs’ awareness that the patient would die
in the foreseeable future was at some point in the last six
months of life. GPs recognized that death would be in the
foreseeable future only in the last week before the decease
in 26% of the patients with a non-cancer death cause ver-
sus in 6% of the cancer patients (see Table 3, p < 0.001).
GPs’ own observations of problems and/or symptoms
made them aware that the patient would die in the fore-
seeable future in 78% of the cancer patients versus 87%
of the patients with another non-sudden cause of death.Information from the medical specialist led to GPs’
awareness of death in the foreseeable future in 53% of
the cancer patients versus 28% of non-cancer patients
(p < 0.001). Particularly in the non-cancer group, GPs
recognized that patients' death would be in the foresee-
able future on the basis of information from home-care
professionals and/or relatives (significant differences be-
tween cancer and non-cancer patients, see Table 3).
Discussion and conclusions
This study shows that for the majority of cancer patients
(99%) and non-cancer patients (85%), the diagnosis of
the disease ultimately leading to death was made before
the last week of life. However this also means that the
diagnosis was not made until the last week of life in 15%
of the non-cancer group. Apparently, it is more difficult
to make the diagnosis for patients with a non-cancer dis-
ease than for patients with cancer. The GPs’ knowledge
about the diagnosis was often based on multiple sources
of information. For the majority of patients, GPs learnt
about the diagnosis through information from the med-
ical specialist. GPs were more likely to rely also entirely
or partly on their own diagnostics or information from
relatives in the case of patients with diseases other than
cancer.
In addition, our results show that GPs sometimes only
became aware that the patient would die in the foreseeable
future late in the disease trajectory. The GP remained un-
aware that death would be in the foreseeable future until
the last week before death in a quarter of the non-cancer
Table 3 Timing of GPs’ awareness that the patient would die in the foreseeable future and sources of information
Cancer Non-cancer
Time between GPs’ awareness and actual death n = 221** n = 68** P-value*
(%) (%)
Not until the last year before death (also including last six months, last month and last week) 207 (94) 65 (96) 0.770
Not until the last six months before death (including the last month and last week) 190 (86) 64 (94) 0.072
Not until the last month before death (including the last week) 66 (30) 41 (60) <0.001
Not until the last week before death 13 (6) 18 (26) <0.001
GPs’ awareness was based on: (more than one answer possible) Cancer Non-cancer
n = 225 n = 71
(%) (%)
GPs’ observation of problems and/or symptoms 175 (78) 62 (87) 0.079
Information from medical specialist 120 (53) 20 (28) <0.001
Information from home-care professionals 6 (3) 9 (13) 0.002
Information from relatives 33 (15) 19 (27) 0.020
Other 15 (7) 7 (10) 0.371
Not applicable 0 (0) 1 (1) 0.240
*Chi-square analyses: statistically significant differences (P < 0.05) between cancer and non-cancer group are in bold.
**8 missing values, including ‘don’t know’ answers.
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cancer patients. This may be related to the fact that there
is no clear diagnosis for some patients, such as the frail
elderly with a general decline towards death. Another ex-
planation may be that in the case of patients with COPD
or chronic heart failure, for instance, the medical specialist
has the main responsibility for the medical treatment of
the patient until a late stage in the disease trajectory. This
may be different in other countries and therefore findings
cannot automatically generalized. If communication be-
tween the GP and medical specialists is poor, the patient’s
diagnosis may long be unknown to the GP, which hampers
a timely start of palliative care provided by the GP.
The fact that GPs were asked to select their last pa-
tient with a non-sudden death may be related to the fact
that GPs selected a relatively large number of cancer pa-
tients. Van der Velden reported in a death certificate
study that about 77,000 people a year die from a chronic
disease in the Netherlands. Just over half, 40,000 (52%),
die from cancer [17]. In our study, 76% of the patients
with a non-sudden death selected by GPs had cancer
and 24% were non-cancer patients. Apparently, GPs as-
sociate a non-sudden death more with cancer than with
a non-cancer disease. The relatively low proportion in
our study of patients with stroke (1%) or dementia (6%)
is particularly striking. One possible explanation for this
under-representation might be that patients with stroke
or dementia are more likely to die in nursing homes
with their own nursing-home physician being respon-
sible for medical care.Recommendations
The present study shows that particularly in the case of
non-cancer patients, GPs sometimes remain unaware of
the diagnosis of the fatal disease until late in the disease
trajectory. It is possible that the GP sometimes only
learns of the diagnosis at a very late stage because the
medical specialist in the hospital is failing to provide the
GP with information. However, it is also possible that a
patient has a known fatal illness (e.g. advanced heart fail-
ure or COPD) but ultimately dies from another cause (e.g.
pneumonia) that has occurred only in the last week before
death. Hence, further research is needed to get more
insight into the reasons for the finding that the diagnosis
of the disease leading to death is only known at such a late
stage in a relatively large group of patients who died non-
suddenly.
However, in general GPs’ late recognition of the fatal
diagnosis and of death in the foreseeable future may
have consequences for advance care planning and timely
anticipation of the evolving symptoms and care needs of
patients. In line with Fitzsimons et al. [5], we would like
to point out the necessity of embracing the palliative
care approach at an early stage of the disease in order
to address the evolving needs of patients with a life-
threatening chronic illness in good time. Future research
is recommended on the disease trajectories from the
diagnosis until the death of patients with chronic pro-
gressive diseases such as heart failure and COPD.
We also recommend a proactive attitude from GPs in pa-
tients with progressive, ultimately terminal diseases. From
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have a reactive, rather than a proactive, attitude in the inter-
actions with their patients [18]. GPs consider it important
for a patient to indicate what support he or she needs and
they do not want to patronise the patient or give care that is
not needed. However, at the end of life a more proactive ap-
proach, e.g. involving initiatives by the GP for advance care
planning, may result in better matching of patients’ and
familymembers’ existing and evolving care needs.Strengths and limitations
A strength of this study is that data are included about
both cancer patients and patients with other chronic dis-
eases and the frail elderly. Previous studies of palliative
care have mainly focused on cancer patients [19]. How-
ever, the net response rate for the GP questionnaire was
not high (36%), although comparable with other recent
surveys among Dutch GPs [20,21]. It is known that Dutch
GPs have a high workload [22], which may explain why
the non-response in this group is often high. It could be
that GPs with a specific interest in palliative care were
more likely to respond, which may have led to overesti-
mation of the GP’s role in making the diagnosis and the
identification of patients' death in the foreseeable future.
Another limitation of this survey is that it only involved
GPs. It would also be interesting to explore the perspec-
tives of medical specialists on making the diagnosis and
on the communication about the diagnosis with the GP,
patient and family. In addition, nurses or close relatives,
for instance, may play an important role in the recognition
that the patient will die within a foreseeable period, and
are also an important information source for the GP. Fu-
ture multi-perspective research on making fatal diagnoses
and on the identification of patients' death in the foresee-
able future is therefore recommended.Additional file
Additional file 1: Questions that are used for the analysis in this
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